News About: Pharm. Industry


Daewoong Bio, “Big pharmas control selecting comparison drugs”

Daewoong Bio(CEO Byung-Gook Yang) announced on the 13th that the company filed an administrative trial to the Central Administrative Appeals Commission, which claimed ‘Cancellation of Choline Alfoscerate Comparison Dr...

Big pharma medical representatives’ careful behavior, creating less pushed-in products

Unlike the last year, pharmaceutical companies have acted differently in regards to ‘pushing products in.’ Medical representatives at pharmaceutical company had forced and pushed products in to distribution companies...

Pharma industry superior in sales and total asset increases to manufacturing industry

Despite the employment cold wave, like the low employment rate for young adults, pharmaceutical companies, such as Ildong Pharmaceutical, Daewoong Pharmaceutical, Boyrung Pharm, JW Pharmaceutical and Huons, are still ...

Sungkyunkwan University Professor Jae-Hyun Lee becomes first president of K0BD Group

The Korea Drug Research Association(Director Dong-Yeon Kim) held the ‘K-BD Group’ foundation ceremony with 150 experts in the pharmaceutical/biotechnology industry, the academic society, the medical field and in devel...

Yuhan Corporation signs supply agreement of AIDS treatments and APIs with Gilead Sciences

Yuhan Corporation announced on the 8th that the company has signed a supply agreement of its AIDS(acquired immunodeficiency syndrome) treatments and HIV APIs(active pharmaceutical ingredients) with ‘Gilead Sciences Ir...

Kolon Life Science’s ‘Invossa-K’ becomes game changer in osteoarthritis market

After being officially launched on 6 November, Kolon Life Science’s(CEO Woo-Seok Lee) ‘Invossa-K Inj’ has been settled as a new ‘game changer’ through various market activities, such as attracting foreign patients fro...

Will all the credits for biotech & pharmaceutical licenses go to MFDS?

The creation of licenses in the biopharmaceutical field, which was scheduled for enforcement last November, has been stuck in the government agency and association level after the pharmacists’ society. The Ministry o...

MOU between KPBMA and KOTRA for Korean pharma’s entry to global markets

The Korea Pharmaceutical and Bio-Pharma Manufacturers Association(Chairman Hee-Mok Won) and the Korea Trade-Investment Promotion Agency(President Jae-Hong Kim, KOTRA) will tighten up their relationship in various fiel...

Which drugs MFDS approved the most this year?

This year, the most therapeutic category approved by the Ministry of Food and Drug Safety was anticoagulants with 6 products, and it was followed by 3 products of anticancer drugs and antihypertensives respectively. ...

Kangstem Biotech acquires approval of world’s first stem cell treatment for atopic dermatitis

Kangstem Biotech(CEO Tae-Hwa Lee) announced on the 5th that it acquired IND(Investigational New Drug) of a Phase III clinical trial for ‘Furestem-AD,’ the world’s first and only stem cell therapeutic product for atopi...

TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.